DK258283A - Fremgangsmaade til fremstilling af et heparinfragment med en molekylvaegt paa 2000 til 5500 og kovalent bundet til antithrombin iii - Google Patents

Fremgangsmaade til fremstilling af et heparinfragment med en molekylvaegt paa 2000 til 5500 og kovalent bundet til antithrombin iii Download PDF

Info

Publication number
DK258283A
DK258283A DK258283A DK258283A DK258283A DK 258283 A DK258283 A DK 258283A DK 258283 A DK258283 A DK 258283A DK 258283 A DK258283 A DK 258283A DK 258283 A DK258283 A DK 258283A
Authority
DK
Denmark
Prior art keywords
iii
anthithrombine
procedure
preparation
molecule weight
Prior art date
Application number
DK258283A
Other languages
Danish (da)
English (en)
Other versions
DK258283D0 (da
Inventor
Desire J Collen
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Publication of DK258283D0 publication Critical patent/DK258283D0/da
Publication of DK258283A publication Critical patent/DK258283A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK258283A 1982-06-10 1983-06-07 Fremgangsmaade til fremstilling af et heparinfragment med en molekylvaegt paa 2000 til 5500 og kovalent bundet til antithrombin iii DK258283A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8203611 1982-06-10

Publications (2)

Publication Number Publication Date
DK258283D0 DK258283D0 (da) 1983-06-07
DK258283A true DK258283A (da) 1983-12-11

Family

ID=20347038

Family Applications (1)

Application Number Title Priority Date Filing Date
DK258283A DK258283A (da) 1982-06-10 1983-06-07 Fremgangsmaade til fremstilling af et heparinfragment med en molekylvaegt paa 2000 til 5500 og kovalent bundet til antithrombin iii

Country Status (8)

Country Link
US (1) US4623718A (de)
EP (1) EP0098814B1 (de)
JP (1) JPS5925802A (de)
AT (1) ATE22899T1 (de)
CA (1) CA1205011A (de)
DE (2) DE98814T1 (de)
DK (1) DK258283A (de)
NO (1) NO157783C (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
EP0337327A1 (de) * 1988-04-09 1989-10-18 Bioiberica, S.A. Verfahren zur Herstellung von neuen Oligosaccharid-Fragmenten durch kontrollierte chemische Depolymerisation von Heparin
US5252557A (en) * 1988-07-25 1993-10-12 Kiyoshi Kita Administration method of antithrombin
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US20040229778A1 (en) * 2003-05-13 2004-11-18 Elmaleh David R. Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
US7498130B2 (en) * 2003-05-13 2009-03-03 Massachusetts General Hospital Method of reducing viral load
US20070196347A1 (en) * 2003-08-12 2007-08-23 Chan Anthony K C Methods for preventing neurological events
CN103743837B (zh) * 2013-12-24 2015-01-21 山东泰邦生物制品有限公司 人抗凝血酶ⅲ肝素结合比例检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12779T1 (de) * 1980-09-30 1985-05-15 Bayer Ag Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.

Also Published As

Publication number Publication date
NO157783C (no) 1988-05-18
DE3366933D1 (en) 1986-11-20
EP0098814B1 (de) 1986-10-15
DK258283D0 (da) 1983-06-07
DE98814T1 (de) 1984-06-20
NO157783B (no) 1988-02-08
US4623718A (en) 1986-11-18
EP0098814A1 (de) 1984-01-18
JPS5925802A (ja) 1984-02-09
CA1205011A (en) 1986-05-27
NO832092L (no) 1983-12-12
ATE22899T1 (de) 1986-11-15

Similar Documents

Publication Publication Date Title
FI981807A (fi) Menetelmä terapeuttisesti käyttökelpoisten starburst-konjugaattien valmistamiseksi
PT76394B (fr) Procede de preparation de nouveaux conjugues associant par liaison covalente une enzyme et un anticorps
IT8119602A0 (it) Composizione apprettante per fibredi vetro impiegabili per il rinforzo di polimeri.
DE3885317T2 (de) Makromolekulare Platin-Antitumorverbindungen.
ATE88723T1 (de) Heparinderivate, verfahren zu deren herstellung und verwendung fuer pharmazeutische zwecke.
ATE16591T1 (de) Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin11-n-alkyl-norscopinether und verfahren zu deren herstellung.
BR8304973A (pt) Mistura de polimero compativel
DK258283A (da) Fremgangsmaade til fremstilling af et heparinfragment med en molekylvaegt paa 2000 til 5500 og kovalent bundet til antithrombin iii
DE3578074D1 (de) Durch pfropfung modifiziertes polyaethylen mit ultrahohem molekulargewicht und verfahren zu dessen herstellung.
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
ES512087A0 (es) "procedimiento de preparacion de organopolisiloxanos de peso molecular elevado".
ES2182833T3 (es) Agentes antitromboticos multimeros polivalentes.
IT8124077A0 (it) Preparazione di geli di polimeri idrofili di alto peso molecolare.
FI882278A0 (fi) Parannettuja kromikatalyyttikoostumuksia ja polymerointimenetelmä, jossa niitä käytetään
ES2013695B3 (es) Compuestos de coordinacion de platino
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
IT8621434A0 (it) Composti politriazinici contenenti gruppi piperidinilammidinici e loro impiego come stabilizzanti per polimeri.
IL84327A0 (en) Pharmaceutical compositions comprising somatostatin
IT8059824V0 (it) Serie di cinque morsetti stringivetro per la costruzione di composizione di arredamento (vetrinette mobili a giorno, ecc.).
FI104254B1 (fi) Menetelmä trombiinia sitovan aineen tuottamiseksi ja siinä käyttökelpoiset DNA-fragmentit, rekombinanttivektorit ja näillä transformoidut solut
NO891651D0 (no) Polymere materialer.
IT8082818A0 (it) Serie di cinque morsetti stringivetro per la costruzione di composizioni di arredamento (vetrinette, mobili a giorno, ecc.).
JPS57175366A (en) Blood anti-coagulant high molecular material
DK550483A (da) Platin- eller palladiumpraeparat og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment